IC2 demonstrated a significant inhibition of tumor growth in the xenografted mice, and the addition of the DGAT1 inhibitor T863 further augmented the anti-tumor efficacy of IC2 (Fig. 7A–C). Here, DGAT1 is linked to neoplasm.